This Medudy course is a video tutorial for physicians on the topic of "Secondary antidiabetics in early pregnancy". The format used here is a so-called "Journal Club Summary", in which we summarize the latest and most clinically relevant studies for you.
The use of non-insulin-based antidiabetic drugs as second-line therapy in pregnant women with type 2 diabetes is increasing. However, the teratogenic risk is unknown.
Therefore, today's study was specifically designed to assess whether the use of non-insulin-based antidiabetic drugs as second-line therapy during the periconceptional period is associated with an increased risk of severe congenital malformations.
Note: All "speakers" appearing in the Medudy videos are AI-based avatars used to improve the didactics of the videos. The people on whom the avatars are based have explicitly consented to their use. All content is based on high-quality scientific sources and is created and reviewed by the Medudy medical team.
At the end of this training you will know:
- the clinical background and relevance of the research question under investigation
- Study design and methodology of the publication to answer the research question
- the results and key takeaways of the publication
- the conclusion of the publication and possible limitations
